德甲通过降低DOT1L的调节来抑制B淋巴瘤细胞的生长

Yuting Wang1, Nan Zhang2, Weilong Shang1

  • 1Department of Microbiology, College of Basic Medical Sciences, Key Laboratory of Microbial Engineering Under the Educational Committee in Chongqing, Army Medical University, Chongqing, China.

PubMed
概括

德克萨米他 (Dex) 通过降低DOT1L表达后转录来杀死B淋巴瘤细胞. 这突出了DOT1L作为潜在的药物标和Dex敏感性在淋巴瘤治疗中的生物标志物.